Effectiveness and Safety of Vedolizumab in Anti-TNF-Naïve Patients With Inflammatory Bowel Disease—A Multicenter Retrospective European StudyUri Kopylov, Marc Ferrante, Luc Biedermann et al.|Inflammatory Bowel Diseases|2018Cited by 70